
外科理论与实践››2019,Vol. 24››Issue (02): 96-99.doi:10.16139/j.1007-9610.2019.02.002
王坚
收稿日期:2019-01-24出版日期:2019-03-25发布日期:2019-04-25通讯作者:王坚,E-mail: dr_wangjian@126.com基金资助:
WANG Jian
Received:2019-01-24Online:2019-03-25Published:2019-04-25| [1] Lee HY, Kim SH, Lee JM, et al.Reoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria[J]. Radiology,2006,239(1):113-121. [2] Chryssou E, Guthrie JA, Ward J, et al.Hilar cholangiocarcinoma: MR correlation with surgical and histological findings[J]. Clin Radiol,2010,65(10):781-788. [3] Ni Q, Wang H, Zhang Y, et al.MDCT assessment of resectability in hilar cholangiocarcinoma[J]. Abdom Radiol(NY),2017,42(3):851-860. [4] Park HS, Lee JM, Choi JY, et al.Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography[J]. Am J Roentgenol,2008,190(2):396-405. [5] Sakamoto E, Nimura Y, Hayakawa N, et al.The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases[J]. Ann Surg,1998,227(3):405-411. [6] 董家鸿, 项灿宏. 肝门部胆管癌的精准外科手术治疗[J]. 中华消化外科杂志,2013,12(3):170-173. [7] Kawabata Y, Hayashi H, Yano S, et al.Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: A safe technique to secure favorable surgical outcomes[J]. J Surg Oncol,2017,115(8):963-970. [8] Kuriyama N, Isaji S, Tanemura A, et al.Transhepatic hilar approach for perihilar cholangiocarcinoma: significance of early judgment of resectability and safe vascular reconstruction[J]. J Gastrointest Surg,2017,21(3):590-599. [9] Nagino M, Ebata T, Yokoyama Y, et al.Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections[J]. Ann Surg,2013,258(1):129-140. [10] Capussotti L, Muratore A, Polastri R, et al.Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival[J]. J Am Coll Surg,2002,195(5):641-647. [11] Hirano S, Kondo S, Tanaka E, et al.Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality[J]. J Hepatobiliary Pancreat Surg,2010,17(4):455-462. [12] Chen XP, Lau WY, Huang ZY, et al.Extent of liver resection for hilar cholangiocarcinoma[J]. Br J Surg,2009, 96(10):1167-1175. [13] Neuhaus P, Jonas S, Bechstein WO, et al.Extended resections for hilar cholangiocarcinoma[J]. Ann Surg,1999, 230(6):808-818. [14] 王坚. 围肝门外科技术处理围肝门胆道肿瘤[J]. 中华外科杂志,2018,56(5):332-337. [15] 王坚, 陈炜. 围肝门外科技术在胆道外科的应用[J]. 中华消化外科杂志,2015,14(4):284-287. [16] 王坚. 围肝门外科技术在肝门部胆肠吻合的应用[J]. 肝胆外科杂志,2018,26(3):164-166. [17] Ni Q, Wang H, Liang X, et al.Successful parenchyma-sparing anatomical sugery by 3-dimensional reconstruction of hilar cholangiocarcinoma combined with anatomic variation[J]. J Coll Physicians Surg Pak,2016,26(6 suppl):S13-S15. [18] 何敏, 王昊陆, 闫加艳, 等. 顺逆结合肝中裂劈开肝门显露法治疗Bismuth Ⅲ、Ⅳ型肝门胆管癌的安全性与疗效分析[J]. 中华外科杂志,2018,56(5):360-366. [19] Loschner C, Nagel SN, Kausche S, et al.Hepatic arterial supply in 1297 CT-angiographies[J]. Rofo,2015,187(4):276-282. [20] 董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版)[J]. 中华消化外科杂志,2011,10(1):20-25. [21] Bai T, Chen J, Xie ZB, et al.Combined portal vein resection for hilar cholangiocarcinoma[J]. Int J Clin Exp Med,2015,8(11):21044-21052. [22] Chen W, Ke K, Chen YL.Combined portal vein resection in the treatment of hilar cholangiocarcinoma: A systema-tic review and meta-analysis[J]. EJSO,2014,40(5):489-495. [23] 中华医学会外科学分会. 胆道手术缝合技术与缝合材料选择中国专家共识(2018版)[J].中国实用外科杂志,2019,39(1):15-20. [24] Mansour JC, Aloia TA, Crane CH, et al.Hilar cholangiocarcinoma: expert consensus statement[J]. HPB(Oxford),2015,17(8):691-699. |
| [1] | 杨传鑫, 王坚.运用精准外科理念提高腹膜后肿瘤外科治疗的规范性与安全性[J]. 外科理论与实践, 2022, 27(06): 517-520. |
| [2] | 王开宇, 王良, 束斌, 张跃伟, 黄鑫, 葛夏青, 肖鸣, 张琪佳, 严哲, 宋研, 项灿宏.肝门胆管癌根治切除联合左半肝及右前叶腹侧段切除(附1例报告)[J]. 外科理论与实践, 2021, 26(05): 441-444. |
| [3] | 李相成, 江王杰.解剖性肝切除的沿革[J]. 外科理论与实践, 2020, 25(01): 20-24. |
| [4] | 李敏, 陶颖, 宋陆军, 倪晓凌, 锁涛, 刘寒, 石洪成, 刘厚宝.CT血管成像评估肝门胆管癌的可切除性[J]. 外科理论与实践, 2019, 24(02): 131-134. |
| [5] | 王吉文, 沈盛, 倪小健, 王越琦, 刘寒, 刘厚宝.三维可视化技术在肝门胆管癌术前评估中的应用[J]. 外科理论与实践, 2019, 24(02): 126-130. |
| [6] | 仇毓东, 毛谅,.肝门胆管癌手术质量控制体系初探[J]. 外科理论与实践, 2016, 21(03): 196-199. |
| [7] | 李相成, 焦臣宇, 王科, 成峰, 姚爱华, 吴晓峰, 沈建, 韩晟, 王东, 季顾惟, 王荇, 王学浩,.肝门胆管癌根治性切除的结果和预后[J]. 外科理论与实践, 2016, 21(03): 206-211. |
| [8] | 陈炜,吴志勇.缺血预处理对肝脏缺血再灌注损伤保护作用的研究[J]. 外科理论与实践, 2003, 8(06): 513-515. |
| [9] | 彭承宏.肝门胆管癌手术难点及对策[J]. 外科理论与实践, 2003, 8(02): 97-98. |
| [10] | 彭淑牖,牟一平,蔡秀军,彭承宏,吴育连,曹利平,江献川,许元良,刘颖斌.Bismuth Ⅲ型肝门胆管癌的外科治疗[J]. 外科理论与实践, 2000, 5(04): 228-230. |
| [11] | 李嘉根,李智涛,仇保渭.肝门胆管癌外科治疗的体会[J]. 外科理论与实践, 1999, 4(03): 237-5. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||